VENUSROUZES LABSOLUTIONS

Their core work

VenusRoses LabSolutions is a Sofia-based private laboratory SME specializing in the chemistry, extraction, and application of bioactive compounds from plants. They contribute analytical and formulation expertise to EU research consortia, working with aromatic plant by-products, herbal extracts, and traditional botanical materials to develop commercially relevant outputs such as cosmeceuticals, food supplements, and treatments for skin conditions. Their scientific grounding spans phytochemistry and pharmacognosy, and they bring a commercially oriented perspective to research networks that are otherwise dominated by universities. In practice, they function as a specialist analytical partner — running experiments, characterizing plant-derived compounds, and linking laboratory results to product development pathways.

What they specialise in

How they've shifted over time

In the earlier project (EXANDAS, 2016–2020), the work was grounded in applied extraction chemistry — turning aromatic plant by-products into high-value cosmetic and food ingredients, with an emphasis on processing efficiency and eco-friendly methods. By the more recent project (EthnoHERBS, 2019–2025), the focus has moved toward ethnobotany and pharmacognosy, anchoring natural products science in traditional knowledge systems and targeting specific clinical outputs such as treatments for skin disorders. The trajectory suggests a deliberate deepening: from valorizing plant waste streams toward building evidence-based bridges between ethnobotanical heritage and pharmaceutical applications.

They are moving from applied cosmetic chemistry toward ethno-pharmaceutical research, a trajectory that positions them well for projects linking biodiversity, traditional knowledge, and evidence-based natural medicine.

How they like to work

VenusRoses LabSolutions has participated exclusively as a consortium partner — never as a coordinator — across both projects, indicating they function as a specialist contributor rather than a project leader. Despite only two projects, they have engaged with 22 unique partners across 12 countries, which reflects the large, internationally distributed structure of MSCA-RISE networks rather than deep bilateral relationships. For a prospective consortium builder, this means they are experienced at operating within complex multi-partner structures but unlikely to drive project management or administrative coordination.

With 22 unique consortium partners across 12 countries from just two projects, their network breadth is disproportionately wide for their project count, a direct consequence of MSCA-RISE's large international consortium model. No geographic concentration is evident beyond a Bulgarian home base.

What sets them apart

Among Bulgarian SMEs in EU research, VenusRoses LabSolutions occupies an unusual niche at the intersection of analytical plant chemistry, traditional ethnobotanical knowledge, and product-oriented applications for skin and health — a combination rarely found in a single private lab of this size. As a private company rather than a university group, they bring commercial grounding to academic-led consortia, which is particularly valuable when projects need to demonstrate market relevance or link results to industry. Their dual competency in cosmeceuticals and pharmacognosy gives them access to both personal care and pharmaceutical/nutraceutical consortium tracks.

Highlights from their portfolio

• EXANDAS
  Largest funding received (EUR 162,000) and clearest commercial orientation — targeting cosmeceutical and food supplement markets through aromatic plant by-product chemistry.
• EthnoHERBS
  Long-running project (2019–2025) with a distinctive scope linking European biodiversity conservation, traditional herbal knowledge, and skin disorder treatment development.